Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/elqXCfbwocfCxxeFYXbg

February 26, 2013
Sign upForwardArchiveAdvertise
Your World of Science News

  Top Story 
 
  • Study: Mice brain cells can live much longer than their bodies
    Brain cells in mice were shown to be capable of surviving at least twice as long as the mice they were once in, according to a study in the journal Proceedings of the National Academy of Sciences. The findings are said to have implications for "life extension enthusiasts" -- if "your neurons do not have a fixed lifetime," then perhaps humans can continue to extend their lifespan, says study co-author Lorenzo Magrassi -- as well as for those looking into neuronal transplants that could help with Alzheimer's or Parkinson's disease. LiveScience.com (2/25) LinkedInFacebookTwitterEmail this Story
"Brilliant" ISAAC'S EYE now EXTENDED through 3/10!
The Scientist calls Lucas Hnath's Isaac's Eye "Thoroughly engaging, thought-provoking & very funny." Now extended through March 10th at The Ensemble Studio Theatre. Use code HOOKE for 25% off tickets. "A quirky sendup of fusty historical dramas... Isaac's Eye wins a whole mess of points for originality." - Charles Isherwood, The New York Times
  Science in the News 
  • Scientists: Life could be possible on Mars now
    As research and exploration continue on Mars and Mars-like surfaces on Earth, some scientists suggest that findings support the theory that microbial life is possible on the planet today. The likelihood that water flows at times on the Red Planet further suggests habitability for some organisms. "We certainly can't rule out the possibility that it's habitable today," said Alfred McEwen of the University of Arizona. Space.com (2/25) LinkedInFacebookTwitterEmail this Story
  • Insects can see "glow" from carnivorous plants, study says
    Carnivorous plants emit ultraviolet light that "glows" in the vision of insects and attracts prey, according to a study in Plant Biology. This glow, previously unseen and unknown by humans, "is the most distinct fluorescent emission found in the plant kingdom," said Sabulal Baby, the study's author and a plant biologist at the Jawaharlal Nehru Tropical Botanic Garden and Research Institute in India. National Geographic News/Weird & Wild blog (2/25) LinkedInFacebookTwitterEmail this Story
  • Institute develops renal cells from stem cells
    A team at the Institute of Bioengineering and Nanotechnology has turned embryonic stem cells into functioning human kidney cells. The cells have the potential for use in regenerative medicine, drug research and the modeling of illnesses. "In particular, we are interested in applying our technology to develop predictive in vitro drug testing and renal toxicity models as alternatives to animal testing," institute Executive Director Jackie Y. Ying said. Yahoo/Indo-Asian News Service (2/22) LinkedInFacebookTwitterEmail this Story
  • NASA plans to discuss black hole findings Wednesday
    NASA is scheduled to reveal findings about black holes at a news conference Wednesday. Scientists will discuss the results of the Nuclear Spectroscopic Telescope Array program studying black holes with high-intensity X-ray light. Space.com (2/25) LinkedInFacebookTwitterEmail this Story
  • Some movement disorders may be rooted in the brain
    People who suffer from little-known movement and muscle disorders commonly referred to as psychogenic diseases showed abnormal brain patterns in a recent study. The cause of these diseases is still unknown, as it has been difficult to detect such differences in brain activity, but the study led by neuroscientist James Rowe of the University of Cambridge used PET scans to find the abnormal brain activity. LiveScience.com (2/25) LinkedInFacebookTwitterEmail this Story
  Research Policy Regulations 
  • Genentech-ImmunoGen breast cancer drug wins FDA approval
    Roche Holding unit Genentech and ImmunoGen obtained FDA approval to market Kadcyla, or ado-trastuzumab emtansine, as a treatment for patients who have HER2-positive, metastatic breast cancer who don't respond to other treatments. Because of associated mortality, liver and heart risks, the drug will carry a boxed warning. The approval means a $10.5 million milestone fee will be paid to ImmunoGen. Reuters (2/22) , Genetic Engineering & Biotechnology News (2/22) LinkedInFacebookTwitterEmail this Story
  Sigma Xi News 
  • Subscribe to American Scientist magazine
      
    Are you taking advantage of everything Sigma Xi, The Scientific Research Society has to offer? American Scientist is the premier interdisciplinary magazine for science and research. Act now and receive a one-year subscription for only $30. Subscribe today. LinkedInFacebookTwitterEmail this Story

  • Connect with us on social media
    Are you active on Facebook, Twitter and LinkedIn? Sigma Xi is, too, and we would love to continue the conversation with you online. Look for us on your favorite platform and let us know your thoughts today. LinkedInFacebookTwitterEmail this Story
Learn more about ->Sigma Xi | American Scientist | Become an Affiliate
Become a Member | Contact Us


  SmartQuote 
Shared joys make a friend, not shared sufferings."
--Friedrich Nietzsche,
German philosopher


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Sales Associate:   Alex Rice   (202) 618-5666
 
Read more at SmartBrief.com
 
 
 Recent Sigma Xi SmartBrief Issues:   Lead Editor:   Bryan McBournie
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.®  Legal Information